Wegovy - European Medicines Agency (EMA)
Wegovy is effective at reducing weight in adults with obesity or who are overweight with a weight-related health problem. It is also effective in adolescents with obesity, but there were not enough data on overweight adolescents.
France won’t pay for weight loss drug Wegovy. What about other European …
Oct 11, 2024 · France is the latest European country to refuse to cover weight loss drugs through its national insurance programme. The anti-obesity drug Wegovy is now available in France – but the government...
EU regulator backs use of Novo's Wegovy for obesity-related …
Sep 19, 2024 · The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker said on Thursday.
Novo Nordisk's Wegovy wins EU backing for reducing heart risks
Jul 26, 2024 · Novo Nordisk’s blockbuster Wegovy weight loss drug has received backing from the European Union’s medical regulator to expand the medicine’s use to include reducing the rise of serious...
European regulatory authority adopts a positive opinion for an …
Bagsværd, Denmark, 25 July 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for...
Novo Nordisk’s Wegovy Gets EU Backing to Treat Obesity-Related …
Sep 20, 2024 · Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure in obese patients.
Novo Nordisk A/S: Wegovy® recommended by the European
Bagsværd, Denmark, 19 September 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion...
UPDATE 2-EU drug watchdog to consider wider use of Wegovy …
Jan 22, 2024 · The European Union's drug regulator will this week consider wider use of Novo Nordisk's weight-loss drug Wegovy to include reducing the risk of strokes and heart attacks.
EU regulator backs use of Novo's Wegovy for obesity-related …
Sep 19, 2024 · (Reuters) -The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker said on Thursday. This...
EU drug watchdog to consider wider use of Wegovy weight-loss …
Jan 22, 2024 · The European Union's drug regulator will this week consider wider use of Novo Nordisk's weight-loss drug Wegovy to include reducing the risk of strokes and heart attacks.